ERG-IN-5 (Compound M1) is a metabolite of ERG-IN-4 ( HY-180918 ), and it is a hERG potassium channel inhibitor with an IC 50 of 1.5 μM. ERG-IN-5 is cytotoxic to MTAP del HCT116 and its CC 50 is 28 nM. ERG-IN-5 can be used for the study of colon cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Potassium Channel | Products > Signaling Pathways > Drug Metabolite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.